DJ Corbus Pharmaceuticals Holdings Inc. Stock Rises Monday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ rallied 1.06% to $9.51 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.22% to 22,374.18 and the Dow Jones Industrial Average rising 0.83% to 46,946.41.
The stock's rise snapped a two-day losing streak.
Corbus Pharmaceuticals Holdings Inc. closed 53.75% short of its 52-week high of $20.56, which the company reached on October 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc. $(VNDA)$ remained unchanged, Fortress Biotech Inc. (FBIO) fell 0.32% to $3.09, and Viking Therapeutics Inc. (VKTX) rose 1.07% to $36.01.
Trading volume (203,504) eclipsed its 50-day average volume of 186,238.
Data source: Dow Jones Market Data, FactSet. Data compiled March 16, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 16, 2026 17:23 ET (21:23 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments